Chemours Co Net Income Loss

• Chemours Co showed a decrease of -659.4% in Net Income Loss from 2024 to 2025.
• This data is from Chemours Co's annual report (Form 10-K), filed with the SEC on February 24, 2026.
• XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2015: -$18.00 million | Q3 2015: -$29.00 million | Q4 2015: -$86.00 million | Q1 2016: $51.00 million | Q2 2016: -$18.00 million | Q3 2016: $204.00 million | Q4 2016: -$230.00 million | Q1 2017: $150.00 million | Q2 2017: $161.00 million | Q3 2017: $207.00 million | Q4 2017: $228.00 million | Q1 2018: $297.00 million | Q2 2018: $281.00 million | Q3 2018: $275.00 million | Q4 2018: $142.00 million | Q1 2019: $94.00 million | Q2 2019: $96.00 million | Q3 2019: $76.00 million | Q4 2019: -$317.00 million | Q1 2020: $100.00 million | Q2 2020: $24.00 million | Q3 2020: $76.00 million | Q1 2021: $96.00 million | Q2 2021: $66.00 million | Q3 2021: $214.00 million | Q1 2022: $234.00 million | Q2 2022: $201.00 million | Q3 2022: $240.00 million | Q4 2022: -$97.00 million | Q1 2023: $145.00 million | Q2 2023: -$376.00 million | Q3 2023: $12.00 million | Q4 2023: -$18.00 million | Q1 2024: $54.00 million | Q2 2024: $60.00 million | Q3 2024: -$32.00 million | Q4 2024: -$11.00 million | Q1 2025: -$5.00 million | Q2 2025: -$380.00 million | Q3 2025: $46.00 million | Q4 2025: -$47.00 million.
• Over the full 13 years of available data (2013 to 2025), Chemours Co's Net Income Loss has declined by 191.3%.
• Historical annual values: Fiscal year 2025: -$386.00 million | Fiscal year 2024: $69.00 million | Fiscal year 2023: -$253.00 million | Fiscal year 2022: $578.00 million | Fiscal year 2021: $608.00 million | Fiscal year 2020: $219.00 million | Fiscal year 2019: -$52.00 million | Fiscal year 2018: $995.00 million | Fiscal year 2017: $746.00 million | Fiscal year 2016: $7.00 million | Fiscal year 2015: -$90.00 million | Fiscal year 2014: $400.00 million | Fiscal year 2013: $423.00 million.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026